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Infection of cells by herpes simplex virus type 1 (HSV-1) triggers host cell shutoff whereby mRNAs are
degraded and cellular protein synthesis is diminished. However, virus protein translation continues because
the translational apparatus in HSV-infected cells is maintained in an active state. Surprisingly, poly(A)-
binding protein 1 (PABP1), a predominantly cytoplasmic protein that is required for efficient translation
initiation, is partially relocated to the nucleus during HSV-1 infection. This relocalization occurred in a
time-dependent manner with respect to virus infection. Since HSV-1 infection causes cell stress, we examined
other cell stress inducers and found that oxidative stress similarly relocated PABP1. An examination of
stress-induced kinases revealed similarities in HSV-1 infection and oxidative stress activation of JNK and p38
mitogen-activated protein (MAP) kinases. Importantly, PABP relocalization in infection was found to be
independent of the viral protein ICP27. The depletion of PABP1 by small interfering RNA (siRNA) knockdown
had no significant effect on viral replication or the expression of selected virus late proteins, suggesting that
reduced levels of cytoplasmic PABP1 are tolerated during infection.
The lytic replication cycle of herpes simplex virus type 1
(HSV-1) can be divided into three phases, immediate-early
(IE), early (E), and late (L), that occur in a coordinated se-
quential gene expression program. IE proteins can regulate E
and L gene expression, which produces proteins involved in
DNA replication, capsid production, and virion assembly. HSV
infection results in host cell shutoff to facilitate the efficient
production of viral proteins. First, mRNA is degraded by the
virion-associated vhs protein, and then ICP27, a multifunc-
tional regulator of gene expression, inhibits pre-mRNA splic-
ing. As most viral mRNAs are intronless, this abrogates the
production of stable cellular mRNAs that can be exported to
the cytoplasm and compete for translation with viral mRNAs
(44).
HSV mRNAs are capped and polyadenylated and so are
translated via a normal cap-dependent mechanism. Transla-
tion initiation, during which translationally active ribosomes
are assembled, is a tightly regulated process (21). Eukaryotic
initiation factor 4F (eIF4F) (composed of eIF4E, eIF4G, and
eIF4A) that binds the cap at the 5 end of the mRNA promotes
the recruitment of the 40S ribosomal subunit and associated
factors, including eIF2-GTP initiator tRNA. The recognition
of the start codon then promotes large ribosomal subunit join-
ing. Poly(A)-binding protein 1 (PABP1), which binds and mul-
timerizes on mRNA poly(A) tails, enhances translation initia-
tion through interactions with the eIF4G component of the
eIF4F cap-binding complex (20, 29, 32, 51) to circularize the
mRNA in a “closed-loop” conformation (24). Key protein-
RNA and protein-protein interactions in the translation initi-
ation complex are strengthened by this PABP1-mediated cir-
cularization (12).
HSV-1 maintains active viral translation in the face of host
translational shutoff. Infection activates protein kinase R
(PKR), which phosphorylates eIF2, resulting in translation
inhibition. However, HSV-1 ICP34.5 redirects protein phos-
phatase 1 to reverse eIF2 phosphorylation, abrogating the
block to translation (17, 38). In addition, the HSV-1 US11
protein inhibits PKR and may also block PKR-mediated eIF2
phosphorylation (40, 42). HSV-1 infection also enhances
eIF4F assembly in quiescent cells by the phosphorylation and
proteasome-mediated degradation of the eIF4E-binding pro-
tein (4E-BP), which, when hypophosphorylated, can negatively
regulate eIF4F complex formation (54). However, ICP6 may
also contribute to eIF4F assembly by binding to eIF4G (55).
Finally, ICP6 is required for Mnk-1 phosphorylation of eIF4E,
but the mechanisms behind this remain unclear (54). ICP27
has also been implicated in translation regulation during HSV
infection (6, 8, 10, 30) and may also activate p38 mitogen-
activated protein (MAP) kinase that can phosphorylate eIF4E
(16, 59).
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PABP1 appears to be a common cellular target of RNA and
DNA viruses. PABP1 can undergo proteolysis, intracellular
relocalization, or modification of its interaction with other
translation factors in response to infection. For example, po-
liovirus induces host cell shutoff by cleaving PABP1, thus dis-
rupting certain PABP1-containing complexes (28, 29). The ro-
tavirus NSP3 protein can displace PABP1 from translation
initiation complexes (41). However, NSP3 also interacts with a
cellular protein, RoXaN, which is required to relocate PABP1
to the nucleus (13). Similarly, the Kaposi’s sarcoma herpesvi-
rus (KSHV) SOX protein plays a role in relocating PABP1, its
cofactor in cellular mRNA decay, to the nucleus (33). Al-
though steady-state levels of PABP1 are highest in the cyto-
plasm of normal cells, where it has cytoplasmic functions, it is
a nucleocytoplasmic shuttling protein (1). However, it is un-
clear how PABP1 enters or exits the nucleus, as it contains
neither a canonical nuclear export nor an import signal.
Here we describe the loss of PABP1 from cap-binding com-
plexes and the partial relocation of PABP1 to the nucleus in
HSV-1-infected cells in a time-dependent manner. Relocation
is specific for PABP1, as other translation factors remained in
the cytoplasm. Cells undergo stress during HSV-1 infection,
and analysis of a variety of cell stresses revealed that PABP
relocalization was also observed upon oxidative stress. Paxillin,
a potential PABP1 nuclear chaperone, was phosphorylated,
and the paxillin-PABP1 interaction was reduced during virus
infection. However, the interaction was weak and cell type
dependent, indicating that other effectors of PABP1 relocation
in the infected cell must exist. Recently, the HSV-1 ICP27
protein was suggested to alter the PABP1 cellular location (6).
However, infections with ICP27-null mutant viruses clearly
demonstrated that ICP27 is not required for PABP1 nuclear
relocation in the context of infection. Although HSV-1
mRNAs are translated by a normal cap-dependent mechanism
known to be enhanced by PABP1, small interfering RNA
(siRNA) knockdown of PABP1 indicated that at late times of
infection, the translation of certain virus late proteins tolerates
very low levels of PABP1.
MATERIALS AND METHODS
Cells and viruses. HeLa and Vero cells were grown to subconfluence in
Dulbecco’s modified Eagles medium (DMEM; Invitrogen) with 10% fetal calf
serum, 50 g/ml penicillin, and 50 g/ml streptomycin at 37°C in 5% CO2. Cells
were infected with HSV-1 wild-type strain KOS1.1 or the HSV-1 ICP27-null
mutant virus 27lacZ, where the ICP27 gene is inactivated by the insertion of a
lacZ gene cassette (49), or the ICP27-null virus d27-1, where the ICP27 promoter
and most of the gene coding sequence have been deleted (43). Virus was ad-
sorbed onto cells for 1 h. Viruses were used at a range of multiplicities of
infection (MOIs) (0.1, 1, 5, and 10) as detailed in the figure legends. Wild-type
virus replication was assessed by titration on BHK-1 cells.
Cell lysis and fractionation. For coimmunoprecipitation experiments, total
cellular protein lysates were obtained by scraping cells into NP-40 lysis buffer
(150 mM NaCl, 50 mM Tris [pH 8.0], 2 mM EDTA, complete miniprotease
inhibitor cocktail mix and complete phosphoSTOP [Roche Diagnostics], and
0.5% NP-40) and pelleting debris by centrifugation at 10,000  g for 5 min in an
Eppendorf microcentrifuge. For Western blot analysis cells were scraped into 2
SDS-polyacrylamide gel loading buffer. DNA was sheared by 10 passes through
an 18-gauge needle and sonication for 30 s in a Sonibath (Kelly Electronics).
Membrane, cytosol, and nuclear cell fractions were prepared by using a Biovision
FractionPREP cell fractionation kit according to the manufacturer’s instructions
(Biovision, CA). Cell numbers were counted, and cell equivalents of total cell
protein or of the various fractions were compared on SDS-PAGE gels.
Western blot analysis. Proteins were fractionated on 4 to 12% gradient SDS-
polyacrylamide gel electrophoresis gels (NuPage; Invitrogen) and transferred
onto a nitrocellulose membrane by using an I-Blot dry blotting system (Invitro-
gen). Membranes were blocked in 5% milk powder in phosphate-buffered saline
(PBS) containing 0.1% Triton X-100 (PBST) for 1 h with shaking. Membranes
were incubated with primary antibodies diluted in 5% milk powder in PBST
overnight at 4°C, and following washing in PBST, they were incubated with
secondary antibody (anti-mouse IgG or anti-rabbit IgG, diluted at 1:2,000 [ECL;
GE Healthcare]) for 1 h with shaking. Following washing in PBST, proteins were
visualized by using ECL Western blotting detection reagent (Pierce, Thermo
Scientific). Monoclonal primary antibodies used were those against PABP1
(10E10), ICP4, ICP8, gC (all Abcam), ICP27 (1119/1113; Virusys Corporation),
S6 ribosomal protein (Cell Signaling Technology), glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (6CS; Biodesign), and SRp20 (7B4; Zymed laborato-
ries), all used at a 1:1,000 dilution. Other monoclonal antibodies were eIF4E
(1:500) and paxillin (1:10,000) (BD Transduction Laboratories) and VP16 (1:
500; Santa Cruz). Polyclonal antibodies used were those against PABP1 (1:5,000;
Abcam) and PABP1 C terminus polyclonal antibody RED2 (1:5,000; a gift from
Simon Morley, University of Sussex), p53 CM-1 (1:1,000; Leica), and connexin
43 (1:1,000; Sigma).
Confocal microscopy. A total of 8  104 cells per coverslip were grown
overnight on sterile 18- by 18-mm coverslips and then infected or mock infected
with virus for the required time period. Cells on coverslips were washed three
times with PBS and fixed in 20% sucrose–5% formaldehyde in PBS for 10 min at
room temperature. After three washes with PBS, the coverslips were permeab-
ilized with a 70% acetone–30% methanol solution for 5 min at 20°C and then
washed three times with PBS and incubated in PBS containing 20% calf serum
for 1 h at room temperature. Cells were incubated with primary antibodies
diluted in 1% calf serum in PBS for 1 h at room temperature: ICP27 (1119/1113,
1:100; Virusys Corporation), ICP4 (1:200; Abcam), PABP1 (10E10; Abcam),
RED2 (1:300; a gift from Simon Morley, University of Sussex), paxillin (1:250;
BD Transduction Laboratories), eIF3 (1:100; Santa Cruz), and eIF4E (1:500;
Abcam). Coverslips were washed in PBS six times before incubation for 1 h with
Alexa Fluor 350, 488, 555, or 647 donkey anti-mouse secondary antibody or
Alexa Fluor 488 or 555 donkey anti-rabbit antibody diluted 1:1,000 in 1% (vol/
vol) calf serum in PBS (Vector Laboratories). After washing in PBS six times,
coverslips were mounted with Vectashield mounting medium (with DAPI [4,6-
diamidino-2-phenylindole] as a nuclear stain). Images were taken by using a
Zeiss LSM510 Meta confocal microscope.
Coimmunoprecipitation. Cell lysates (500 g) were RNase treated (5 g)
prior to use by incubation for 1 h at 37°C. For immunoprecipitation, protein G
beads (Sigma) were washed three times in NP-40 lysis buffer. Beads were used to
preclear lysates by incubation for 1 h at 4°C with rotation. Supernatants were
incubated with 1 g polyclonal antibody (PAIP2, SRPK1 [Santa Cruz], and
paxillin [Abcam]) for 1 h at 4°C before the addition of fresh, washed protein G
beads (50-l slurry) and overnight incubation at 4°C. Beads were pelleted and
washed five times with NP-40 lysis buffer. After a final wash, beads were sus-
pended in SDS-PAGE loading buffer and boiled for 5 min. Beads were pelleted
by a brief centrifugation, and supernatants were analyzed by SDS-PAGE.
Irradiation and drug treatment of cells. HeLa cells were seeded at 105 cells
per well in 24-well culture dishes containing sterile coverslips. Cells were allowed
to settle for 24 h at 37°C. Medium was removed, and cells were irradiated by
using a gamma irradiation cobalt60 source (0.5 to 20 Gy). Fresh medium was
added to each well, and cells were placed into a CO2 incubator overnight at 37°C.
A range of concentrations and a range of times of incubation with tunicamycin,
thapsigargin (dissolved in dimethyl sulfoxide [DMSO]), and H2O2 (dissolved or
diluted in H2O) were also tested. The final concentration and dosage time of
each drug used were the highest that did not cause apoptosis, as noted in the
figure legends in each case. Drugs were added to media prior to being added to
cells. Controls were cells treated with drug vehicle alone.
Transient transfection and siRNA knockdown. For the ectopic expression of
ICP27, HeLa cells on coverslips in 24-well dishes were transiently transfected
with 0.1 g per well of plasmid pEGFP-C1, encoding ICP27, by using Attractene
(Qiagen). The medium was replaced after 24 h. Cells were fixed 48 h after
transfection and processed for confocal immunofluorescence microscopy. For
siRNA knockdown, a pool of three siRNA duplexes that target PABP1 RNA was
purchased from Santa Cruz. Cells were transfected at 50% confluence in six-well
dishes with 10 nM siRNA using Lipofectamine RNAiMax (Invitrogen) diluted in
Opti-MEM (Invitrogen). Fresh medium without antibiotics was added to each
well and incubated at 37°C in 5% CO2 for 24 h. Cells were infected with HSV-1
at an MOI of 5 and harvested 16 h postinfection. For virus titration, plates were
frozen at 80°C, and detached cells were harvested and sonicated for 30 s in a
Sonibath (Kelly Electronics). Virus was titrated on BHK-21 cells at 90% con-
fluence.
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RESULTS
PABP1 subcellular distribution changes during HSV-1 in-
fection. PABP1 enhances translation efficiency and is emerging
as a viral target, contributing, in some cases, to host shutoff
during infection (3, 13, 53). To investigate any effect of HSV-1
infection on PABP1, we analyzed PABP1 levels and subcellu-
lar localization in mock-infected and HSV-1-infected HeLa
cells. In the experiment shown in Fig. 1A, a multiplicity of
infection of 1 was used in order to be able to visualize unin-
fected cells adjacent to infected cells. PABP1 was predomi-
nantly cytoplasmic in mock-infected cells. A very similar pic-
ture was observed with cells infected for 6 h (Fig. 2 and data
not shown). However, at 9 h (Fig. 1A) and 12 h (Fig. 2 and data
not shown) postinfection, PABP1 levels were increased in the
nuclei of the subpopulation of cells that displayed features
consistent with late events in the virus replication cycle. For
example, these cells displayed replication centers that stained
positive for the virus transcription factor ICP4 (Fig. 1A), and
cells appeared rounded up, indicative of late ongoing infection.
Relocation of PABP1 was not observed for cells that did not
express ICP4 (Fig. 1A). Relocalization was observed at a range
of multiplicities of infection (0.1, 1, and 10) and was specific to
PABP1, as other proteins involved in translation, eIF4E (Fig.
1B) and eIF3 (data not shown), remained in the cytoplasm
until cells showed evidence of apoptosis. PABP1 relocalization
was also observed for Vero cells (Fig. 2 and see Fig. 4A and
Table 1), showing that it was not cell type specific. PABP1
relocalization was only partial, as some cytoplasmic PABP1
could be observed even at 16 h postinfection (Fig. 1B).
Biochemical subcellular fractionation experiments were car-
ried out to confirm the confocal immunofluorescence data.
Total cellular protein and cytosol, membrane, and nuclear
fractions were prepared (Fig. 1C). Analysis of whole-cell ex-
tracts indicated that total PABP1 levels were not changed after
9 h of infection. The purity of the nuclear fraction was dem-
onstrated by Western blotting with an antibody against SRp20,
a splicing factor that is mainly nuclear at steady state (Fig. 1C,
lanes 3 and 6). As a marker for the translation apparatus, we
used the S6 ribosomal protein. The S6 ribosomal protein was
found mainly in the membrane and cytosolic fractions (Fig. 1C,
lanes 1, 2, 4, and 5). This is because there are two types of
ribosomes, “free” ribosomes located in the cytosol and mem-
brane-bound, endoplasmic reticulum (ER)-associated ribo-
somes. A trace of S6 ribosomal protein was detected in the
nuclear fraction. This is likely due to polyribosomes being
attached to the nuclear membrane. The S6 ribosomal protein
acts as a control for the location of ribosome-associated
PABP1. GAPDH was found mainly in the cytosolic fraction
(Fig. 1C, lanes 1 and 4), as expected. There was little difference
in the subcellular locations of the control proteins between
mock-infected and HSV-1-infected cells. However, PABP1
was clearly partially redistributed in HSV-1-infected cells. In
mock-infected cells PABP1 was found mainly in the membrane
fraction (Fig. 1C, lane 2), with some located in the cytoplasm,
similar to the location of the S6 ribosomal protein. PABP1 was
also found in the nucleus, as expected, as it has nuclear func-
tions (11). In contrast, in HSV-1-infected cells, although
PABP1 was still present in the cytosol (Fig. 1C, lane 4), levels
were reduced in the membrane fraction (Fig. 1C, lane 5) but
increased in the nuclear fraction (Fig. 1C, lane 6). HSV-1
infection did not change the subcellular location of the S6
ribosomal protein, indicating that changes in PABP1 location
are not due to a general disruption of the translation appara-
tus. There may appear to be a greater relocation of PABP1 to
the nucleus in this experiment compared to the confocal data
shown in Fig. 1A due to the increased multiplicity of infection
of 5 used in this biochemical fractionation experiment.
PABP1 is relocated during HSV-1 infection in a time-depen-
dent manner. HeLa and Vero cells were infected for 3, 6, 9,
and 12 h with HSV-1 at a multiplicity of infection of 1. Con-
focal microscopy was used to examine the PABP1 location at
FIG. 1. Confocal microscopy analysis of PABP1 location during
HSV-1 infection. (A) Immunofluorescence microscopy images of the
PABP1 (green) location in mock-infected (mock) and wild-type HSV-
1-infected (HSV-1) HeLa cells. A multiplicity of infection of 1 was
used in each case of virus infection, and cells were examined at 9 h
postinfection. Costaining with ICP4 (red) was used to monitor virus
infection and to mark virus replication centers. Cells were counter-
stained with DAPI (blue) to locate nuclei. Arrowheads indicate a cell
where PABP1 has moved to the nucleus and replication centers are
forming. An arrow indicates an uninfected cell with cytoplasmic
PABP1. (B) Cells infected with wild-type HSV-1 were reacted with
PABP1 antibody (green) or an antibody against the translation factor
eIF4E (red) and then examined by confocal microscopy. Cells were
counterstained with DAPI (blue) to locate nuclei. Bar, 10 m.
(C) Western blot analysis of relative levels of PABP1 in cytoplasmic
(C), membrane (M), and nuclear (N) fractions of HeLa cells either
mock infected (Mock) or infected with wild-type HSV-1 at a multi-
plicity of infection of 5 for 9 h. S6 rp, S6 ribosomal protein, a marker
of the ribosome location in cytoplasmic and membrane fractions.
GAPDH is a marker of cytoplasmic fractions. SRp20 is a marker of
nuclear fractions. ICP27 marks virus-infected extracts.
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each infection time point. Cells that showed expression of
ICP4 were counted for each time point (200 cells). Two sepa-
rate experiments for each cell line were carried out, with very
similar results. Data from one experiment are shown. The
number of cells that displayed predominantly nuclear PABP1
increased with time postinfection, with the majority of cells
(70%) containing some nuclear PABP1 by 12 h postinfection
(Fig. 2).
Oxidative stress causes relocalization of PABP1 to the nu-
cleus. HSV infection leads to JNK and p38 MAP kinase acti-
vation (11, 16, 59). JNK and p38 MAP kinase activation is also
a common feature of cell stress. Cells frequently respond to
stress by downregulating global translation (50). Some induc-
ers of cell stress cause PABP1 localization to cytoplasmic stress
granules. However, the loss of PABP1 from the cytoplasm to
the nucleus at late times of HSV-1 infection could be a differ-
ent response to cell stress linked to the virus-induced stress
response. Figure 3A confirms that most JNK and p38 MAP
kinases were robustly activated during HSV-1 infection. This
suggests that PABP1 nuclear relocalization may also occur
following other cell stresses where PABP1 is not relocalized to
stress granules. Therefore, uninfected cells were stressed by
various means, including gamma irradiation-induced DNA
damage, ER and oxidative stress, and the location of PABP1
was examined by confocal microscopy. We tested a range of
drug concentrations and radiation doses. Experiments were
carried out under conditions where full apoptosis was not ob-
served, as judged by evidence of fragmentation of DAPI-
stained DNA and cell detachment from culture flasks. Changes
in PABP1 location were not observed in most cases, including
gamma irradiation of cells (Fig. 3C). However, treating cells
with inducers of oxidative stress caused changes in PABP1
subcellular localization. PABP1 relocated to the nucleus fol-
lowing 2 h of treatment with between 500 and 1,000 M hy-
drogen peroxide (Fig. 3D). Although quantitative differences
were observed, qualitatively, the hydrogen peroxide activation
of stress kinases had a profile similar to that seen with HSV-1
infection (Fig. 3B). In particular, both treatments of Vero cells
resulted in a significant activation of JNK2 and p38 MAP
kinases (Fig. 3A and B). As HSV-1 infection and hydrogen
peroxide cause ER stress (34, 37, 52), we also investigated
whether ER stress results in the relocation of PABP1. The
effect of known inducers of ER stress, tunicamycin (10 g/ml)
(Fig. 3E) or thapsigargin (2 M) (data not shown), was tested
on HeLa cells. Neither drug induced PABP1 relocation at
concentrations known to induce ER stress. The incubation of
cells with drug vehicle alone also did not cause relocation in
any case (e.g., see Fig. 3F). HSV-1 infection is known to induce
oxidative stress (26). We suggest that PABP1 subcellular relo-
cation during HSV-1 infection may be a direct and selective
response to virus-induced oxidative stress.
Paxillin may contribute to PABP1 relocalization to the nu-
cleus. The cell attachment, spreading, and motility regulator
protein paxillin has been shown to interact directly with
PABP1, and it was previously suggested to contribute to
PABP1 export from the nucleus (57, 58). Thus, changes to
paxillin in HSV-1-infected cells could cause a redistribution
of PABP1 to the nucleus. Paxillin is found at focal adhesions at
the leading edge of migrating cells (5) but is also located to the
perinuclear endoplasmic reticulum (58). In uninfected Vero
FIG. 2. PABP1 relocates to the nucleus in wild-type HSV-1-infected Vero and HeLa cells in a time-dependent manner. HeLa and Vero cells
on coverslips were infected at a multiplicity of infection of 1 with wild-type HSV-1, and coverslips were harvested at 3, 6, 9, and 12 h postinfection
(hpi). For each time point, ICP4-positive cells were counted (200 cells in each case). Patterns of staining were categorized into PABP1 location
mainly in the cytoplasm (cytoplasmic PABP1) (black bars) or mainly in the nucleus (nuclear PABP1) (gray bars). Dividing cells and cells that had
similar levels of PABP1 present in both compartments (less than 10% of the total cell population) were not counted. Two separate experiments
for each cell line were carried out, with very similar results. Data from one such experiment are shown.
TABLE 1. Occupancy of PABP1 in HSV-1 infected cellsa
Time
postinfection (h)
Mean % occupancy of PABP1  SEM
Vero cells HeLa cells
Cytoplasm Nucleus Cytoplasm Nucleus
6 68.3  8.2 11.1  3.1 74.5  6.9 13.2  2.5
16 11.2  4.2 67.7  13.8 7.2  1.9 50.7  10.4
a Cells on coverslips at a confluence of 70% were infected with HSV-1 at a
multiplicity of infection of 1. At either 6 or 16 h postinfection, cells were fixed
onto coverslips by incubation in 20% sucrose–5% formaldehyde in PBS for 10
min at room temperature. Antibody staining and immunofluorescence confocal
microscopy were carried out with a Zeiss LSM 500 confocal microscope. Cell
pictures were counted blind by two individuals. Cells showing evidence of virus
infection by the detection of ICP4 expression from images from three different
experiments (500 cells for each experiment) were counted in each case. Only
nondividing cells were counted. Cells where there was a significantly higher level
of PABP1 in the nucleus than in the cytoplasm were counted as having nuclear
PABP1. Around 5 to 10% of cells showed similar levels of PABP1 in the nucleus
and cytoplasm, and these cells were not counted.
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cells, paxillin showed a diffuse cytoplasmic location (Fig. 4A).
Very few focal adhesions were observed, but paxillin localized
to any that were present (data not shown). In HSV-1-infected
Vero cells, paxillin was also found in the cytoplasm but had a
more perinuclear location. However, in infected Vero cells,
although some PABP1 was present in the same perinuclear
location as paxillin, a significant portion relocated to the nu-
cleus (Fig. 4A). Paxillin phosphorylation regulates its subcel-
lular localization (7), and the paxillin that interacts with and
exports nuclear PABP1 was previously reported to be hypo-
phosphorylated (57). Thus, the hyperphosphorylation of pax-
illin could induce a nuclear accumulation of PABP1 by causing
paxillin to remain in the cytoplasm or by inhibiting the forma-
tion of exportable nuclear PABP1-paxillin complexes. A com-
parison of the paxillin protein from mock-infected and HSV-
1-infected Vero cells showed that HSV-1 infection induced
significant changes in the mobility of paxillin on SDS-PAGE
gels (Fig. 4B). The treatment of total cell extracts from mock-
and HSV-1-infected cells with calf intestinal alkaline phos-
phatase indicated that the decreased mobility of paxillin
isolated from HSV-1-infected cells was due to changes in phos-
phorylation (Fig. 4C). To assess the formation of PABP1-
paxillin complexes, coimmunoprecipitation was carried out on
mock-infected and infected cell extracts. A small amount of
paxillin was found in complex with PABP1 in mock-infected
Vero cells, but no paxillin-PABP1 interaction could be dem-
onstrated for HSV-1-infected Vero cells (Fig. 4D). Paxillin was
present in infected cell lysates and could be precipitated with
the anti-paxillin antibody used. PAIP2, a binding partner of
PABP1 (27), could efficiently precipitate PABP1 from mock-
infected or HSV-1-infected Vero cell extracts (Fig. 4E). No
coimmunoprecipitation was observed with the control anti-
body, SR protein kinase 1 (SRPK1), which is involved in RNA
metabolism but has not been reported to bind paxillin or
PAIP2. Our finding that the PABP1-paxillin interaction in
uninfected cells was hard to detect casts doubt over the extent
to which the observed loss of this interaction might contribute
to PABP1 relocalization in Vero cells. Indeed, PABP1-paxillin
interactions were unable to be detected in HeLa cells (data not
shown) where PABP1 is also relocated to the nucleus, suggest-
ing that this interaction is highly unlikely to account for the
nuclear accumulation of PABP1 during HSV-1 infection.
ICP27 is not required for PABP1 relocation to the nucleus
during HSV-1 infection. Recently, it was reported that the
ectopic expression of the HSV-1 protein ICP27 caused in-
creased nuclear levels of PABP1 (6). We confirmed that the
ectopic overexpression of green fluorescent protein (GFP)-
labeled ICP27 results in the relocation of PABP1 to the nu-
cleus (Fig. 5A). To explore whether ICP27 also causes PABP1
relocation during HSV-1 infection, HeLa cells were infected
FIG. 3. Oxidative stress induces PABP1 relocation to the nucleus.
(A) Relative levels of activated, selected signaling MAP kinases in
mock-infected (black bars) and HSV-1-infected (dark gray bars) Vero
cells (16 h postinfection at a multiplicity of infection of 5) assessed by
using the Proteome Profiler Array human phospho-MAPK array kit
(R&D Systems, Minneapolis, MN) according to the manufacturer’s
instructions. (B) Relative levels of activated, selected signaling MAP
kinases in mock-treated (black bars) and hydrogen peroxide-treated
(1,000 M for 2 h at 37°C) (light gray bars) Vero cells assessed using
the same array kit as that described for panel A. The graphs show the
means and standard errors of the means from three separate experi-
ments, although standard errors of the means were very low, and error
bars lie very close to the tops of the bars on the graphs. Asterisks
indicate JNK and p38 MAP kinases whose activities increased signif-
icantly upon both HSV-1 infection and hydrogen peroxide treatment.
(C to F) Confocal immunofluorescence microscopy analysis of the
effects of irradiation, or selected drug treatments, on PABP1 location
in uninfected HeLa cells. (C) Gamma irradiation (-IR) does not alter
the subcellular location of PABP1. Irradiation was tested between 0.5
and 20 Gy. The image shows cells irradiated to 20 Gy and incubated
overnight at 37°C. (D) Oxidative stress was induced with 1,000 M
hydrogen peroxide (H2O2) and incubation for 2 h at 37°C, with signif-
icant PABP relocation to the nucleus. (E) ER stress does not cause
PABP1 relocation to the nucleus. ER stress was induced by the treat-
ment of cells with 10 g/ml tunicamycin (TM) for 8 h at 37°C. (F)
Mock-treated cells (control [cntl]). Significant levels of cell death were
not observed under any of the conditions used. Bar, 10 m.
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with the ICP27 mutant virus 27lacZ, where the ICP27 gene is
disrupted by the insertion of a lacZ gene. If ICP27 was involved
in PABP1 relocation, then no relocation should be observed
for cells infected with the ICP27-null mutant virus. Figure 5B
shows that in cells infected with HSV-1 27lacZ (arrowed cells),
PABP1 relocated to the nucleus in a manner similar to that
observed for cells infected with wild-type HSV-1 (Fig. 1A). A
very similar result was obtained when cells were infected with
d27.1, an ICP27 deletion mutant virus (data not shown). Cells
infected with the ICP27 mutant viruses did not become
rounded up, and replication centers were not as well formed as
in the cells infected with wild-type virus, as expected. This is
because ICP27 is required for efficient virus DNA replication,
and infection proceeds more slowly with ICP27 mutant viruses
(35). However, in cells where replication centers were begin-
ning to form (ICP4-positive cells), PABP1 clearly relocated to
the nucleus. Quantification of numbers of cells with mainly
cytoplasmic versus mainly nuclear PABP1 demonstrated a sim-
ilar time-dependent relocation of PABP1 to the nucleus, al-
though the numbers of cells with predominantly cytoplasmic
PABP1 did not fall as low as those in wild-type HSV-1-infected
cells, again likely due to differences in the course of infection
with ICP27 mutant viruses (Fig. 5C).
Reduction in PABP1 levels does not affect progression of
HSV-1 infection or synthesis of virus late proteins. HSV-1
replicates in the nucleus, and virus mRNAs are capped and
polyadenylated, like cellular mRNAs. Therefore, the efficient
translation of viral mRNAs requires an active cellular transla-
tion machinery. Decreased PABP1 levels in the cytoplasm at
late times of virus infection would be predicted to have a
negative impact on virus translation and replication. The level
of PABP1 associated with cap-binding complexes was shown to
be decreased in HSV-1-infected cells (6). Since HSV-1
mRNAs are capped and polyadenylated, the loss of PABP1
from the translational apparatus would be predicted to be
detrimental to HSV-1 translation and replication. However,
our observations suggest that the loss of PABP1 may be toler-
ated.
To test whether virus replication was altered by the absence
of PABP1, siRNA knockdown was performed. A pool of
PABP1-specific siRNAs knocked down PABP1 by around 90%
over a 24-h period (Fig. 6A). Cells were treated with siRNA for
72 h prior to infection with HSV-1 at a multiplicity of infection
of 0.1. At 24 h following infection, virus replication was mea-
sured by determining virus titers. No significant difference in
virus replication was noted for HSV-1-infected HeLa cells
FIG. 4. The interaction of paxillin with PABP1 is disrupted in HSV-1-infected Vero cells. (A) Immunofluorescence microscopy analysis of the
subcellular locations of paxillin (green) and PABP1 (red) in mock-infected (mock) and HSV-1-infected (HSV-1) Vero cells. Infection was carried
out at a multiplicity of infection of 5 for 9 h. DNA in the nuclei is counterstained with DAPI (blue). (B) Western blot analysis of the mobility of
the paxillin protein from mock-infected (M) and HSV-1-infected (HSV-1) Vero cells on SDS-PAGE gels. The lower portion of the Western blot
was probed with GAPDH antibody to demonstrate equal protein loading. (C) Calf intestinal alkaline phosphatase (CIP) at 1 U/g protein was
added to protein lysates and incubated for 1 h at 37°C. Proteins were fractionated on SDS-PAGE gels and Western blotted with an anti-paxillin
antibody or a GAPDH antibody control. M, mock-infected cell lysate; HSV-1, HSV-1-infected cell lysate. (D and E) Coimmunoprecipitation of
PABP1 from mock-infected or HSV-1-infected Vero cells with paxillin (D) and PAIP2 (E), a known PABP1-interacting protein (27). (Top)
Western blot (WB) analysis of immunoprecipitation (IP) of PAIP2- or paxillin-containing complexes fractionated by SDS-PAGE and Western
blotted with PABP1 antibody. (Bottom) Results of Western blotting of the coimmunoprecipitated complexes with the cognate antibody. Pax,
paxillin antibody used in coimmunoprecipitation; PAIP2, PAIP2 antibody used in coimmunoprecipitation; SRPK1, SRPK1 antibody used as a
control antibody; M, mock-infected cell lysate; HSV-1, HSV-1-infected cell lysate. Input lanes contained 10% of the quantity of cell lysate used
in the coimmunoprecipitation experiments.
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pretreated with PABP1 siRNAs compared to cells pretreated
with control siRNA (Fig. 6D). Western blotting was used to
examine whether a reduction in PABP1 levels altered viral
protein synthesis. We did not examine ongoing translation in
infected cells using metabolic labeling because siRNA knock-
down of PABP1 was achieved prior to virus infection, so any
effect on virus protein production should be observed at
steady-state protein levels. Moreover, metabolic labeling fol-
lowing PABP knockdown could not be used to measure host
protein synthesis because host shutoff means that very little
host mRNA translation is occurring late in virus infection.
Figure 6B shows data for virus protein production in cells
treated with control or PABP1 siRNAs for 24 h and then either
mock infected or infected with HSV-1 for 16 h. Levels of
ICP27, an immediate-early protein; ICP8, an early protein; and
VP16 and gC, both true late proteins, were examined by West-
ern blotting. No significant difference in protein levels was
detected following HSV-1 infection of cells pretreated with
control siRNAs or with PABP1 siRNAs (Fig. 6B), although a
slight reduction in VP16 levels was observed for HSV-1-in-
fected, PABP1 siRNA-pretreated cells. Metabolic labeling in-
dicated a reduction of 78% in host translation in uninfected
cells upon treatment with PABP1 siRNA. To discover whether
PABP1 knockdown had any effect on host cell mRNA trans-
lation during virus infection, we chose to examine steady-state
levels of two proteins with short half-lives (Fig. 6C). Following
PABP1 knockdown, proteins already synthesized will remain
detectable in the cell by Western blotting if they have long
half-lives, i.e., they are not degraded during the experiment
(for example, GAPDH), or efficient translation of their
mRNAs is not PABP1 dependent. Conversely, levels of pro-
teins with very short half-lives should be depleted at steady-
state levels upon PABP1 siRNA treatment. Connexin 43
(Cx43) is a gap junction protein found at the membrane and in
the cytoplasm and has a half-life of 1.5 to 2 h. p53 is a nuclear
protein with a half-life of approximately 30 min. Levels of both
FIG. 5. ICP27 does not cause PABP1 relocation to the nucleus
during HSV-1 infection. (A) HeLa cells were transiently transfected
with a plasmid encoding GFP-tagged ICP27 and 48 h later examined
for ICP27 expression (green) and PABP1 localization (red) by immu-
nofluorescence confocal microscopy. Nuclei were counterstained with
DAPI (blue). Arrowheads indicate cells where PABP1 is found in the
nucleus. Bar, 10 m. (B) HeLa cells were infected with HSV-1 ICP27
mutant virus 27lacZ at a multiplicity of infection of 1 and examined 9 h
postinfection by confocal immunofluorescence microscopy. Arrow-
heads indicate cells where PABP1 (red) has relocated to the nucleus.
Cells were also stained with antibody against ICP4 (green) to mark
prereplication centers and counterstained with DAPI to locate nuclei.
(C) Graph showing the distribution of PABP1 in HeLa cells infected
with 27lacZ at a multiplicity of infection of 1 for various times. Very
similar data were obtained with infections of Vero cells. Cell growth,
analysis, and counting were exactly as detailed in the legend to Fig. 2.
Two separate experiments were carried out, with very similar results.
Data from one such experiment are shown.
FIG. 6. Reduced levels of PABP1 in cap-binding complexes do not
compromise virus replication or translation of selected viral proteins.
(A) Western blot panel showing levels of PABP1 in mock- and HSV-
1-infected cells treated with control siRNA (C) or PABP1 siRNA
(P) for 24 h. The graph shows the means and standard errors of the
means from quantifications, using Image J, of the band intensity rel-
ative to that of GAPDH controls from four separate experiments.
(B) Cell lysates were prepared from HeLa cells that were first trans-
fected with control siRNAs (C) or PABP1 siRNAs (P) for 24 h and
then either mock infected (mock) or infected with HSV-1 (HSV-1) for
16 h at a multiplicity of infection of 5. Proteins were fractionated on
SDS-PAGE gels and Western blotted with the antibodies against cel-
lular and viral proteins shown on the right-hand side. (C) The same cell
lysates used as described for panel B were fractionated on SDS-PAGE
gels and Western blotted with the antibodies against connexin 43
(Cx43) and p53. (D) HeLa cells were transfected with control siRNAs
or with PABP1 siRNAs for 72 h and then infected with HSV-1 at a
multiplicity of infection of 0.1 for 24 h. Virus was titrated on BHK
cells, and the titer was measured in PFU/ml. The means and standard
errors of the means from four experiments are shown.
VOL. 84, 2010 ICP27-INDEPENDENT PABP1 NUCLEAR RELOCALIZATION 8545
proteins were reduced in uninfected and infected cells treated
with PABP1 siRNA compared to cells treated with control
siRNA. In control siRNA-treated, HSV-1-infected cells, levels
of the two proteins were detected but at somewhat reduced
levels. Cx43 was undetected in HSV-1-infected PABP1 knock-
down cells, while p53 was still able to be detected. This lack of
a complete depletion of p53 during infection may be related to
the previously observed virus stabilization of p53 (4). These
data indicate that PABP siRNA treatment of cells can inhibit
protein synthesis but that HSV-1 replication can proceed effi-
ciently even in the presence of reduced levels of PABP1 and
that at least some virus proteins are still able to be translated
to normal levels.
DISCUSSION
Although mainly cytoplasmic at steady state, PABP1 can be
found in the nucleus during infection with certain viruses,
including rotavirus (13) and Kaposi’s sarcoma herpesvirus
(KSHV) (2, 33). Herpesviruses replicate in the nucleus, where
the cellular RNA processing machinery adds 5 caps and 3
poly(A) tails to viral mRNAs. Thus, herpesvirus mRNAs
mimic cellular mRNAs during translation. Like other viruses,
it is possible that the reorganization of the translation appara-
tus ensures the preferential translation of viral mRNAs (48).
The role of PABP1 in enhancing the translation of capped and
polyadenylated mRNAs prompted an investigation of the ef-
fect of HSV-1 infection on PABP1 during the course of HSV-1
infection. Confocal microscopy and biochemical fractionation
demonstrated a significant time-dependent accumulation of
PABP1 in the nuclei of cells beginning after 6 h postinfection
with wild-type HSV-1, consistent with a reduction in levels of
PABP1 in cap-binding complexes. However, a complete relo-
cation of PABP to the nucleus at late times of virus infection
did not occur even at very late times of infection in cells with
fully formed replication centers.
During the preparation of the manuscript, another labora-
tory reported that the ectopic overexpression of ICP27 caused
a relocation of PABP1 to the nucleus, and those researchers
concluded that ICP27 is a key regulator of PABP1 redistribu-
tion (6). We have also observed that the overexpression of
ICP27 causes PABP1 nuclear relocation. However, it is clear
from our experiments using ICP27-null mutant viruses that
ICP27 is not necessary for the relocation of PABP1. Dobrikova
et al. (6) reported that UL47 may also be implicated in PABP1
relocation. However, UL47 is a tegument protein that has roles
early in virus infection at times when PABP relocation is not
observed. Moreover, ICP27 transcriptionally regulates UL47
(22). This protein cannot contribute to PABP1 relocation, as it
is not expressed at significant levels in cells infected with the
27lacZ or d27.1 virus. These data indicate that although ICP27
and PABP1 are found in the same complexes (10), ICP27 is not
responsible for relocating PABP1 to the nucleus.
In HSV-1-infected cells there is an overall reduction in cel-
lular mRNA levels due to virus inhibition of cellular transcrip-
tion (47) and the degradation of cellular mRNAs. Early in
infection, the vhs protein degrades all RNAs (46), and later in
infection, ICP27 inhibits splicing, leading to an uncoupling of
the RNA processing and RNA export pathways (14, 15, 45).
Most viral mRNAs do not contain introns, so they are still
efficiently exported to the cytoplasm (23). However, cellular
mRNA export is significantly disrupted, and it seems likely that
retained cellular mRNAs are degraded because fluorescence in
situ hybridization confocal microscopy has demonstrated no
net nuclear accumulation of polyadenylated RNA in HSV-1-
infected cells (23). However, infection of cells with certain
HSV-1 ICP27 mutant viruses can result in polyadenylated
RNA accumulation in the nucleus (23). The ectopic overex-
pression of ICP27 could have an effect similar to that of these
mutants by blocking cellular splicing and, therefore, mRNA
export. Since PABP1 is known to bind pre-mRNAs in the
nucleus (18), this raises the possibility that nuclear PABP1 may
be associated with retained mRNAs.
The overexpression of PABP1 was previously shown to re-
sult in its accumulation in the nucleus (1); however, our data
clearly establish that overall PABP1 levels are not increased
during HSV-1 infection (Fig. 1C), and thus, this cannot ac-
count for our observations. The PABP1-paxillin interaction has
been suggested to control levels of nuclear PABP1. HSV-1
infection seemed to disrupt this interaction, perhaps due to an
altered phosphorylation of paxillin (57), which is observed dur-
ing virus infection (Fig. 4B). Paxillin is known to be a target of
JNK and p38 MAP kinase (19), both of which are activated
during virus infection (Fig. 3A). However, it is clear that only
a very small pool of PABP1 binds paxillin in uninfected cells,
and the binding may be cell type specific, as we were unable to
consistently detect a paxillin-PABP1 interaction in HeLa cells.
Thus, the importance of the disruption of the paxillin-PABP1
interaction in HSV-1 infection may be low.
Virus binding and entry, replication, and protein translation
all contribute to the induction of cellular stresses, including
DNA damage (34), ER stress (37), oxidative stress (26), and
apoptosis (39). Consistent with this, the stress-activated pro-
tein kinase pathways, particularly JNK and p38 MAPK, are
activated during HSV-1 infection (16). Although mechanisms
exist to reduce the stress-related disruption of the translation
apparatus during HSV-1 infection (36), it is possible that
PABP1 is evicted from the polyribosomes as a result of HSV-
1-induced cell stress. Unlike in HSV-1 infected cells, the treat-
ment of uninfected cells with many different exogenous stress
inducers did not induce PABP1 relocation to the nucleus.
However, the direct induction of oxidative stress resulted in a
clear relocation of PABP1 to the nucleus. Hydrogen peroxide
treatment mimicked the qualitative changes in selected JNK
and MAP kinases activated during HSV-1 infection. In partic-
ular, JNK2 and p38 MAP kinase were activated by both types
of cell stress. A direct causative link between HSV-1-induced
oxidative stress and PABP1 nucleocytoplasmic localization re-
mains to be established. However, although DNA damage
induced by gamma irradiation did not induce PABP1 nuclear
relocation, UV irradiation causes significant PABP1 entry into
the nucleus (our unpublished data). Although UV irradiation
causes DNA damage, it also induces oxidative stress. One
effect of oxidative stress that we are currently investigating may
be to inhibit the export of nuclear PABP1.
Many viruses have evolved mechanisms of disrupting
PABP1 as a means of host cell shutoff. For example, the po-
liovirus 3C protease cleaves PABP1 on polyribosomes (29),
and the rotavirus NSP3 protein competes with PABP1 for
eIF4G binding (13). However, it remains to be determined
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whether PABP1 relocalization in HSV-1 or KSHV (25, 33)
plays a similar role. For instance, in HSV-1-infected cells, most
cellular mRNAs are considered to be significantly depleted
within the cytoplasm by late times, making additional PABP1-
related shutoff mechanisms redundant. Indeed, PABP relocal-
ization would be predicted to also impact efficient viral trans-
lation. To investigate whether PABP1 is required for the
translation of HSV-1 late proteins, we depleted PABP1 levels
in cells and then infected them with HSV-1. Total cellular
PABP1 levels were very significantly decreased in our siRNA
knockdown experiments, and cellular translation was reduced
by almost 80%. Although it is possible that translation could
tolerate very low levels of PABP1, steady-state levels of two
cellular proteins were significantly reduced following PABP1
siRNA treatment, indicating that PABP1 knockdown could
alter at least some cellular translation. Surprisingly, there was
no obvious reduction in virus replication levels or in the pro-
duction of selected steady-state virus proteins, including true
late proteins, despite the efficient siRNA knockdown of
PABP1 prior to virus infection. This means that the translation
of virus proteins can tolerate very low levels of PABP1. This
may be due to the lack of cellular mRNAs reducing competi-
tion for the translational apparatus. Consistent with this idea,
human cytomegalovirus (HCMV), a herpesvirus that does not
degrade cellular mRNAs, increases cellular levels of PABP
and its recruitment into cap-binding complexes (2, 53, 56).
Alternatively, HSV-1 may compensate for low levels of PABP1
on the polysomes by remodeling the translation apparatus to
ensure efficient viral protein production (31). Several virus
proteins, including ICP27, ICP6, and ICP0, have been impli-
cated in the efficient assembly of the translation initiation com-
plex (8, 9, 30, 55) and the phosphorylation of eIF4E, which
regulates translation (54). It remains to be seen whether these
proteins have a direct effect on translation during virus infec-
tion, perhaps to compensate for the loss of PABP1 on the
polyribosomes.
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